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Abstract
Background—Cut points for defining obesity have been derived from mortality data among
Whites from Europe and the United States and their accuracy to screen for high risk of coronary
heart disease (CHD) in other ethnic groups has been questioned.
Objective—To compare the accuracy and to define ethnic and gender-specific optimal cut points
for body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR) when they
are used in screening for high risk of CHD in the Latin-American and the US populations.
Methods—We estimated the accuracy and optimal cut points for BMI, WC and WHR to screen
for CHD risk in Latin Americans (n=18 976), non-Hispanic Whites (Whites; n=8956), non-
Hispanic Blacks (Blacks; n=5205) and Hispanics (n=5803). High risk of CHD was defined as a
10-year risk ≥20% (Framingham equation). The area under the receiver operator characteristic
curve (AUC) and the misclassification-cost term were used to assess accuracy and to identify
optimal cut points.
Results—WHR had the highest AUC in all ethnic groups (from 0.75 to 0.82) and BMI had the
lowest (from 0.50 to 0.59). Optimal cut point for BMI was similar across ethnic/gender groups (27
kg/m2). In women, cut points for WC (94 cm) and WHR (0.91) were consistent by ethnicity. In
men, cut points for WC and WHR varied significantly with ethnicity: from 91 cm in Latin
Americans to 102 cm in Whites, and from 0.94 in Latin Americans to 0.99 in Hispanics,
respectively.
Conclusion—WHR is the most accurate anthropometric indicator to screen for high risk of
CHD, whereas BMI is almost uninformative. The same BMI cut point should be used in all men
and women. Unique cut points for WC and WHR should be used in all women, but ethnic-specific
cut points seem warranted among men.
Keywords
coronary heart disease; screening; ethnic group; Latin America; NHANES
Introduction
Obesity is a recognized risk factor for the development of cardiovascular diseases and for
all-cause mortality among ethnic groups in the United States.1,2 Also among Latin
Americans, that is, Hispanics living in their country of origin, obesity doubles the risk of
coronary heart disease (CHD)3 and seems to contribute to an excess of 18 to 49% in the risk
of coronary events.4 In view of the large impact of obesity on cardiovascular risk,
anthropometric indicators of obesity are commonly used as a tool to identify individuals and
populations at high risk of cardiovascular events.
Body mass index (BMI) is a measure of overall obesity, whereas waist circumference (WC)
and waist-to-hip ratio (WHR) are used as indicators of abdominal obesity. Although these
obesity indicators have been independently associated with CHD incidence and mortality in
different populations,5-7 several investigators and public health organizations have recently
questioned whether cut points derived from Whites from Europe and the United States are
appropriate for use in other populations.8-10 For instance, the World Health Organization
(WHO) has recently suggested lowering BMI action cut points to 23 and 27.5 kg/m2 for
Asians,8 and the International Diabetes Federation’s guidelines for assessing metabolic
syndrome recommends the use of South Asian’s WC cut points for Latin Americans and
makes no recommendation for cut points among Blacks from the United States.11 In this
study we used data from six Latin-American countries and from the United States National
Health and Nutrition Examination Survey (NHANES) to compare the accuracy of BMI, WC
Herrera et al. Page 2
Int J Obes (Lond). Author manuscript; available in PMC 2009 May 27.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
and WHR, that is, their ability to correctly classify individuals as having a high or a low risk
of CHD. We also estimated ethnic and gender-specific optimal cut points for these
anthropometric indicators when they are used in screening for high risk of CHD.
Methods
Study data came from the Latin-American Consortium of Studies in Obesity, a partnership
of studies on the burden, etiology and consequences of obesity in the region (http://
www.pophealth.wisc.edu/laso). Eight health surveys from six countries (Chile, Colombia,
Dominican Republic, Perú, Puerto Rico and Venezuela) were included in this analysis
(Table 1).4,12-18 All participants in these studies were categorized as ‘Latin Americans’ for
the purpose of the present analysis. Each survey was approved by an Institutional Review
Board and all participants provided their informed consent. We certify that all applicable
institutional and governmental regulations concerning the ethical use of human volunteers
were followed during this research. Standing height and weight were measured in all
surveys with the participants wearing light clothing and no shoes. WC was measured at the
umbilical level in three studies,4,16,18 at the midpoint between the lowest rib and the iliac
crest in three studies,12,13,15 at the high point of the iliac crest in one study17 and was not
measured in another.14 Hip circumference was only measured in five studies, at the
maximum extension of the buttocks.4,13,16-18 Blood pressure measurements were
conducted at least twice in all but one study15 following standard recommendations.21
Blood samples were obtained in all studies after ≥8 h of fast and serum glucose, total
cholesterol and high density lipoprotein cholesterol were measured enzymatically by
automated methods.
Data from the United States population came from NHANES III (1988-1994)19 and from
NHANES 1999-2000, 2001-2002 and 2003-2004 (Table 1).20 Sampling weights were not
used in the calculation of area under receiver operator characteristic (ROC) curve (AUC).
However, failure to account for sampling weighting does not change the consistency of the
AUC estimates, because probability weighting does not affect either the shape or location of
the conditional distributions.22 Racial/ethnic categories identification in NHANES was self-
reported. Due to sample size limitations, native Americans and Asian Americans from the
United States were excluded from this analysis. WC was measured at the high point of the
iliac crest and hip circumference was measured at the maximum extension of the buttocks
(only in NHANES III). Three to four blood pressure measurements were taken following
standard procedures23 and blood glucose and lipids were measured by automated methods.
NHANES data were statistically weighted to maintain the representativeness of the sample
for the US population.24
In the absence of incident data, ethnic and gender-specific optimal cut points for BMI, WC
and WHR were identified as those that maximized the correct classification of individuals
according to their expected risk of CHD. We used the Framingham equation to estimate the
expected 10-year risk of CHD in 30- to 74-years old men and women.25 Persons with an
estimated 10-year risk of CHD ≥20% were considered at ‘high risk’, because currents
standards of care recommend aggressive risk reduction and selective use of proven drug
therapies in these individuals.26,27 We used multivariate imputation by chained equations
to fill out missing values and generated 10 imputed datasets, separately for each study, to
minimize selection bias due to missing data.28 One strength of this method is that it does not
assume a particular form for the multivariate distribution of the data, that is, multivariate
normal. The imputation model included sociodemographic variables (age, gender, race,
education and area of residency), anthropometric indicators (weight, height, waist and hip
circumference) and cardiovascular risk factors (blood pressure, smoking status, plasma
glucose, total, LDL- and HDL-cholesterol and triglycerides). Non-normally distributed
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variables were log transformed to improve the model’s fit. Ten cycles of regression
switching were carried out to generate each imputed dataset as recommended.28 The
parameters of interest were averaged across the 10 imputed datasets, using Rubin’s formula.
29 For our imputation model, we assumed that data were missing at random, that is, missing
values, such as blood pressure, could be predicted with observed values in other variables,
such as the subject’s gender, age, and BMI, among other variables. In this scenario, an
analysis based on multiple imputation is likely to yield estimates that are less biased than
those from an analysis based on complete data.30
We drew empirical ROC curves and calculated the AUC to assess the accuracy of each
anthropometric indicator in screening for high risk of CHD. We also calculated the
sensitivity of each marker at a fixed specificity of 80%, because a false-positive rate ≥20%
was deemed unacceptable for screening purposes. ROC curves and AUCs were estimated
nonparametrically using the method of placement values,31-33 and confidence intervals
were obtained by bootstrapping. Finally, we tested if the accuracy of BMI, WC and WHR
differed in the whole sample as well as within groups defined by ethnicity, gender and age
(<60 years vs ≥60 years).
For the estimation of ethnic and gender-specific optimal cut points for each indicator we
gave equal weight to the consequences of misclassifying individuals, that is, we gave the
same importance to false-negative and false-positive results and used a prevalence of high
risk of CHD of 50% in our calculations.34 This approach fully exploits the data available
and facilitates comparison of the different anthropometric indicators.34 Standard errors for
the cut points were obtained by bootstrapping. Optimal cut points were estimated in a
randomly selected 50% training sample from a randomly selected imputed data. The
sensitivity and specificity of these cut points were evaluated in the remaining 50% validation
sample, because cut point performance would appear better if assessed with the same data
from which cut points were derived than it will appear in an independent dataset. We also
compared the sensitivity and the specificity of study-derived and standard cut points in the
validation sample. This approach provides a valid comparison, because the validation
sample was not used to estimate study-derived or standard cut points. For BMI and WC, we
used the standard cut points recommended by the WHO,35 and for WHR those
recommended by Bray (1.00 for men and 0.90 for women).36 Ethnic and gender-specific cut
points were compared using a t-test and pooled estimates were calculated using a random
effects model.37
Results
This study included 18 976 participants from Latin America, 10 878 participants from
NHANES III and 9086 from NHANES 1999-2004, who were 30-74 years old (Table 1).
The variable with the largest percentage of missing/imputed values was blood glucose at
11.9%. The average BMI was lowest in Latin-American women and men (26.2 and 27.2 kg/
m2, respectively) and highest in white men (28.5 kg/m2) and black women (31.8 kg/m2;
Table 2). Latin-American men and women also had the smallest WC and WHR of all ethnic
groups, whereas Hispanic men and women had the largest WHR, and white men and black
women had the largest WC. Latin Americans had the lowest levels of all cardiovascular risk
factors, with the exception of average systolic and diastolic blood pressure. Moreover, the
prevalence of high risk of CHD ranged from 9.3% in Hispanics to 13.3% in Latin
Americans.
WC was strongly correlated with BMI (r=0.83) and WHR (r=0.67), whereas the correlation
between BMI and WHR was only moderate (r=0.28). In all ethnic groups, WHR had the
highest accuracy in screening for high risk of CHD, followed by WC and then by BMI
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(Table 3). Correspondingly, the AUCs for WHR ranged from 0.75 in Latin Americans to
0.82 in Whites; those for WC ranged from 0.62 in Blacks to 0.70 in Whites; and those for
BMI from 0.50 in Blacks to 0.59 in Whites. Moreover, all indicators performed significantly
better in Whites, and within each ethnic group all were consistently more accurate in women
than in men and in individuals <60 years of age than those in ≥60 years old (data not
shown).
The sensitivity reached at a fixed specificity of 80% for BMI was very low in all ethnic
groups, with a maximum of 25% in Whites (Table 4). Similarly, for WC the maximum
sensitivity was only 41% among Whites. On contrast, the sensitivity of WHR varied from
56% among Latin Americans to 67% among Whites. Within each ethnic group, the
differences in sensitivity at 80% specificity were all statistically significant (P<0.05).
Similar to the AUCs, all three indicators had the highest sensitivities in younger individuals
and in women.
Optimal cut points among women for BMI ranged from 27.4 kg/m2 in Whites to 28.3 kg/m2
in Blacks; however, there were no significant differences between ethnic groups and the
pooled average cut point in women was 27.8 kg/m2 (Table 5). In men, optimal BMI cut
points were homogeneous among ethnic groups and varied from 25.4 kg/m2 in Hispanics to
27.9 kg/m2 in Whites, with a pooled average of 26.6 kg/m2. In addition, within each ethnic
group there were no significant gender differences in the optimal BMI cut points. For the
whole population, the pooled average of the optimal cut point for BMI was 26.7 kg/m2 (95%
confidence interval: 26.0-27.3).
Among women, optimal cut points for WC were homogeneous among ethnic groups and
ranged from 93.0 cm in Latin Americans to 96.8 cm in Whites, with a pooled average of
94.0 cm (Table 5). In contrast, among men, the WC optimal cut points varied significantly
among ethnic groups, from 91.0 cm in Latin Americans to 102.1 cm in Whites, with a
pooled average of 96.8 cm. Moreover, WC optimal cut points were significantly higher in
white men and Hispanic men than in women of the corresponding ethnicity. However, in
Latin Americans and Blacks WC optimal cut points were similar in men and women.
Optimal cut points for WHR among women ranged from 0.87 in Latin Americans to 0.93 in
Blacks, with a pooled average of 0.91 (Table 5). Among men, WHR optimal cut points
varied from 0.94 in Latin Americans to 0.99 in Hispanics, with a pooled average of 0.96. In
addition, WHR optimal cut points were significantly higher in men than in women in
Whites, Hispanics, and Latin Americans. In contrast, WHR optimal cut points were similar
in black men (0.95) and women (0.93).
The sensitivity and specificity of a BMI≥30 kg/m2 (WHO definition) were 47 and 69% in
women (Table 6). Reducing the cut point to 28 kg/m2 resulted in a higher sensitivity of 63%
(relative increment of 35%) and a lower specificity of 57% (relative reduction of 17%).
Among men, the sensitivity and specificity of the WHO definition were 28 and 78%,
respectively. Reducing the cut point to 27 kg/m2, the sensitivity was increased to 52%
(relative increment of 85%) and the specificity was reduced to 56% (relative reduction of
28%). When a unique cut point of 27 kg/m2 (our pooled estimate for women and men) was
used, it yielded a sensitivity of 54% and a specificity of 52%.
In women, abdominal obesity defined as a WC≥88 cm yielded a sensitivity of 83% and a
specificity of 42% (Table 6). Increasing the cut point to 94 cm results in a lower sensitivity
of 71% (relative reduction of 15%) and a higher specificity of 58% (relative increment of
40%). A WHR cut point of 0.90 yielded a sensitivity of 68% and a specificity of 66%. When
the cut point was increased to 0.91 in women (our pooled estimated), the sensitivity was
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reduced to 62% (relative reduction of 9%) and the specificity was increased to 70% (relative
increment of 7%).
In men, a WC cut point of 102 cm yielded a sensitivity of 45% and a specificity of 73%
(Table 6). This cut point coincided with the one estimated from our data in Whites.
Implementing the ethnic-specific cut points derived from Blacks (95 cm), Hispanics (99 cm)
and Latin Americans (91 cm) the corresponding sensitivities and specificities were 69 and
53, 56 and 66, and 80 and 38%, respectively. On the other hand, using the pooled cut point
of 97 cm (Table 5) yielded a sensitivity of 62% and a specificity of 60%.
A definition of abdominal obesity in men as a WHR≥1.00 yielded a sensitivity of 51% and a
specificity of 79%. The implementation of ethnic-specific cut points in Whites (0.98),
Blacks (0.95), Hispanics (0.99) and Latin Americans (0.94) yielded sensitivities and
specificities of 62 and 70, 78 and 52, 56 and 75, and 82 and 46%, respectively. On the other
hand, using the pooled cut point of 0.96 (Table 5) yielded a sensitivity of 74% and a
specificity of 58%.
Discussion
Our results indicate that WHR is the anthropometric indicator with the highest accuracy to
screen for high risk of CHD, followed by WC and then by BMI. These results were
consistent in Whites, Blacks, Hispanics and Latin Americans, and across age and gender
groups. Although BMI is the most used indicator in clinical practice, its accuracy in
identifying high risk of CHD seems very limited. In fact, the AUC results indicate that if a
patient with high risk (case) and another with low risk of CHD (non-case) are selected at
random, BMI will be higher in the case slightly over 50% of the time, whereas WC and
WHR will be higher 65 and 80% of the time, respectively. Moreover, in the best scenario
(among Whites), for a fixed 20% false-positive rate BMI will identify only 2/8 cases
whereas WC and WHR will identify 2/5 and 2/3 cases, respectively. These findings are
consistent with those from a large multinational case-control study38 and from a prospective
study among Europeans39 in which the association with CHD was strongest for WHR,
intermediate for WC and weakest for BMI.
We also found that the accuracy of all three anthropometric indicators is higher in Whites
compared to the other ethnic groups. This may be explained by differences in the strength of
the association between measurements of obesity and cardiovascular risk across ethnic
groups. In support of this, Okuson et al.40 found a stronger association between overall and
abdominal obesity and the coexistence of hypertension and diabetes in Whites than in
Blacks and Mexican Americans in the US population. On the other hand, the better
performance of indicators of obesity in Whites may also reflect a more accurate estimation
of the risk of CHD in this ethnic group, because the Framingham equation was originally
developed on a predominantly white cohort.
Interestingly, the accuracy of the three indicators of obesity was higher in young individuals
(<60 years old) and in women in the four ethnic groups. Similar differences in the accuracy
by age and sex have been previously reported in populations from the US41 and Latin
America.42
In contrast to what has been suggested for Asians,8-10 we found that a unique optimal cut
point for BMI can be used in individuals from different ethnic backgrounds, as well as in
men and women. This is consistent with BMI being almost uninformative in screening for
high risk of CHD. The BMI optimal cut point found in our study (~27 kg/m2) was slightly
higher than those from previous studies. For instance, in Brazilians aged 30-74 years Pitanga
et al.43 found that the best cut points to screen for high risk of CHD were 24 kg/m2 in men
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and 26 kg/m2 in women. Also, in Whites from the United States, Zhu et al.44 found optimal
cut points of 26 kg/m2 in men and 25 kg/m2 in women in screening for at least one
cardiovascular risk factor. Overall, a definition of obesity as BMI≥30 kg/m2 had a very low
sensitivity particularly among men (28%). Lowering this cut point to 27 kg/m2 in all ethnic
groups would increase sensitivity to 52% in men and 63% in women. Whether this finding
could be extrapolated to other ethnic groups is uncertain.
The optimal cut points for the indicators of abdominal obesity differed significantly by
gender in Whites and Hispanics but not in Blacks or Latin Americans. This finding provides
support for the current recommendation of using gender-specific cut points for WC and
WHR in Whites. It is also consistent with those from Okosun et al.,41 who found gender-
dependent cut points for WC in Whites and Hispanics but not in Blacks, and those from
Sanchez-Castillo et al.,42 who found the same WC cut point in Latin-American men and
women. Further efforts aimed to validate anthropometric indicators of abdominal obesity
with direct measurement of visceral adiposity may help in explaining why the performance
of these indicators differs in men and women of different ethnic background.
In our study the optimal cut points for WC and for WHR were similar among women of
different ethnicity. In contrast, WC and WHR optimal cut points were significantly lower in
black and Latin-American men than in white men. The differences (7.1 cm and 0.03 units in
Blacks and 11.1 cm and 0.04 units in Latin Americans) are unlikely explained by random
measurement error or by systematic differences in the site for WC measurements. In fact,
Wang, et al.45 have shown that measurements of WC at different sites are highly reliable
(intraclass correlation coefficient ≥0.99) and that the absolute differences are not larger than
1.6 cm in men and 4.6 cm in women, compared to the method used in NHANES (WC
measured immediately above the iliac crest). More important, WC values measured at
different sites are almost equally associated with total body fat and trunk fat.45 Although
WC and WHR may have been underestimated in Latin Americans, as a consequence of site
of measurement, the degree of underestimation was too small to explain the observed
difference in the optimal cut points. This is particularly true in men, because the WC cut
point was 11.1 cm lower in Latin Americans than in Whites, whereas the expected
difference attributable to site of measurement is not larger than 2 cm. A larger amount of
visceral adipose tissue adjusted for total fat and age in white than in black men, but not in
women, may partly explain why different WC and WHR cut points are needed in white and
black men.46
The inclusion of eight health surveys based on random samples from different regions of
Latin America and the Caribbean, as well as the inclusion of a representative sample of the
US population constitutes one of the major strengths of our study. In this regard, our results
may be generalizable not only to ethnic groups in the US, but also to Latin Americans.
Importantly, our analysis was based on the contrast of AUCs, an approach that allows for
direct comparisons of the accuracy of BMI, WC and WHR, independently of their metrics,
and is not affected by the high correlation between these indicators. Moreover, by using
multiple imputation we likely decreased the potential selection bias and the loss of power
that would have resulted from excluding from the analysis those individuals with missing
values in one or more study variables.30 On the other hand, results based on the analysis of
individuals without missing values (listwise deletion) were very similar to those obtained
using multiple imputation (data not shown).
Using the Framingham equation to predict CHD risk is also a strength of our study, because
the accuracy of anthropometric indicators likely varies for different cardiovascular risk
factors. In contrast, the Framingham equation summarizes most major risk factors and is
widely used for clinical decisions. D’Agostino has shown that the Framingham equation
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accurately predicts CHD risk in whites and Blacks, but may overestimates the absolute risk
of CHD in Latin Americans.47 However, the degree of overestimation is reduced by using
ethnic-specific mean values for risk factors and should not bias our results, as far as it is
independent from the degree of obesity. We also recognize that gathering data from different
studies may introduce some systematic error, particularly if different measurement methods
have been used. However, risk factors and anthropometric measures followed similar,
widely used protocols in all the studies. We recognized the inherent difficulties in the
definition of ethnicity and that individual ethnic groups identified in our study are likely
heterogeneous in their genetic background as well as on their cultural attitude and
environmental exposures.48,49 This is particularly true for the Latin-American group, which
includes individuals of European, African and indigenous origins living in different
countries. Consequently, our definition of ethnic groups is mostly based on our goal to
generate knowledge applicable to the epidemiologic surveillance, planning and delivery of
health care in populations in a geographic area.
In summary, our results show that WHR is the anthropometric indicator with the best
accuracy to identify individuals at high risk of CHD, whereas BMI is almost uninformative.
In addition, our results do not support the use of ethnic-specific cut points for BMI in the
whole American population or for WC and WHR in women; however, ethnic-specific cut
points for WC and WHR among men seem warranted.
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Ta
bl
e 
5
O
pt
im
al
 c
ut
 p
oi
nt
s f
or
 a
nt
hr
op
om
et
ric
 in
di
ca
to
rs
 o
f o
be
sit
y 
to
 id
en
tif
y 
in
di
vi
du
al
s a
t h
ig
h 
ris
k 
of
 c
or
on
ar
y 
he
ar
t d
ise
as
e 
by
 e
th
ni
ci
ty
 a
nd
 g
en
de
r
Et
hn
ic
ity
Cu
t p
oi
nt
 (9
5%
 co
nfi
de
nc
e i
nte
rva
l)
Bo
dy
 m
as
s i
nd
ex
 (k
g/m
2 )
W
ai
st 
ci
rc
um
fer
en
ce 
(cm
)
W
ai
st-
to
-h
ip
 ra
tio
W
om
en
 
W
hi
te
27
.4
 (2
3.4
, 3
1.4
)
96
.8
 (9
2.1
, 1
01
.5)
0.
89
 (0
.86
, 0
.93
)
 
B
la
ck
28
.3
 (2
4.2
, 3
2.1
)
95
.5
 (8
9.5
, 1
01
.4)
0.
93
 (0
.90
, 0
.96
)
 
H
isp
an
ic
27
.8
 (2
4.9
, 3
0.7
)
93
.5
 (9
1.6
, 9
5.4
)
0.
92
 (0
.90
, 0
.95
)
 
La
tin
 A
m
er
ic
an
27
.9
 (2
4.4
, 3
1.3
)
93
.0
 (8
7.0
, 9
9.0
)
0.
87
 (0
.84
, 0
.90
)
 
A
lla
27
.8
 (2
6.1
, 2
9.6
)
94
.0
 (9
2.4
, 9
5.6
)
0.
91
 (0
.88
, 0
.93
)
M
en
 
W
hi
te
27
.9
 (2
6.4
, 2
9.4
)
10
2.
1 
(98
.4,
 10
5.8
)†
0.
98
 (0
.96
, 1
.00
)†
 
B
la
ck
26
.2
 (2
5.5
, 2
6.9
)
95
.0
 (9
1.2
, 9
8.8
)*
0.
95
 (0
.94
, 0
.97
)*
 
H
isp
an
ic
25
.4
 (2
2.0
, 2
8.8
)
99
.2
 (9
5.4
, 1
03
.0)
†
0.
99
 (0
.97
, 1
.01
)†
 
La
tin
 A
m
er
ic
an
26
.4
 (2
3.8
, 2
8.9
)
91
.0
 (8
7.3
, 9
4.7
)*
0.
94
 (0
.93
, 0
.95
)*†
 
A
lla
26
.6
 (2
5.7
, 2
7.6
)
96
.8
 (9
2.0
, 1
01
.6)
0.
96
 (0
.94
, 0
.98
)
*
P 
v
al
ue
 <
0.
05
 fo
r c
om
pa
ris
on
s b
et
w
ee
n 
Bl
ac
ks
, H
isp
an
ic
s a
nd
 L
at
in
 A
m
er
ic
an
s v
s W
hi
te
s (
ref
ere
nc
e g
rou
p)
† P
 
v
al
ue
 <
0.
05
 fo
r c
om
pa
ris
on
s b
et
w
ee
n 
m
en
 an
d 
w
om
en
.
a P
oo
le
d 
es
tim
at
es
 a
nd
 9
5%
 co
nf
id
en
ce
 in
te
rv
al
s b
as
ed
 o
n 
ra
nd
om
 ef
fe
ct
s m
et
a-
an
al
ys
is.
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Ta
bl
e 
6
Se
ns
iti
vi
ty
 a
nd
 sp
ec
ifi
ci
ty
 o
f t
he
 c
ut
 p
oi
nt
s c
ur
re
nt
ly
 re
co
m
m
en
de
d 
to
 d
ef
in
e 
ob
es
ity
 a
nd
 o
pt
im
al
 c
ut
 p
oi
nt
s d
er
iv
ed
 fr
om
 o
ur
 st
ud
y
In
di
ca
to
r a
Cu
t p
oi
nt
s
Cu
rr
en
tly
 re
co
m
m
en
de
d 
a
St
ud
y d
er
iv
ed
Bo
dy
 m
as
s i
nd
ex
 (k
g/m
2 )
W
om
en
/m
en
30
/3
0
28
/2
7
 
W
om
en
Se
ns
iti
vi
ty
46
.5
 (4
2.3
, 5
0.9
)
62
.6
 (5
8.5
, 6
6.8
)
Sp
ec
ifi
ci
ty
68
.9
 (6
8.0
, 6
9.8
)
57
.1
 (5
6.2
, 5
8.1
)
 
M
en
Se
ns
iti
vi
ty
27
.9
 (2
6.2
, 2
9.6
)
51
.7
 (4
9.8
, 5
3.6
)
Sp
ec
ifi
ci
ty
78
.4
 (7
7.4
, 7
9.5
)
56
.2
 (5
5.0
, 5
7.5
)
W
ai
st 
ci
rc
um
fe
re
nc
e (
cm
)
W
om
en
/m
en
88
/1
02
94
/9
7
 
W
om
en
Se
ns
iti
vi
ty
83
.2
 (7
9.7
, 8
6.7
)
70
.9
 (6
6.7
, 7
5.1
)
Sp
ec
ifi
ci
ty
41
.5
 (4
0.4
, 4
2.5
)
58
.1
 (5
7.1
, 5
9.2
)
 
M
en
Se
ns
iti
vi
ty
45
.2
 (4
3.2
, 4
7.2
)
62
.3
 (6
0.4
, 6
4.3
)
Sp
ec
ifi
ci
ty
73
.0
 (7
1.8
, 7
4.2
)
59
.5
 (5
8.2
, 6
0.9
)
W
ai
st-
to
-h
ip
 ra
tio
W
om
en
/m
en
0.
90
/1
.0
0
0.
91
/0
.9
6
 
W
om
en
Se
ns
iti
vi
ty
67
.6
 (6
2.5
, 7
2.7
)
61
.5
 (5
6.2
, 6
6.8
)
Sp
ec
ifi
ci
ty
65
.5
 (6
4.2
, 6
6.8
)
70
.1
 (6
8.8
, 7
1.3
)
 
M
en
Se
ns
iti
vi
ty
50
.5
 (4
7.8
, 5
3.2
)
73
.5
 (7
1.1
, 7
5.9
)
Sp
ec
ifi
ci
ty
78
.6
 (7
7.1
, 8
0.2
)
58
.3
 (5
6.5
, 6
0.2
)
a C
ut
 p
oi
nt
s r
ec
om
m
en
de
d 
by
 th
e 
W
H
O
35
 fo
r b
od
y 
m
as
s i
nd
ex
 an
d 
w
ai
st 
ci
rc
um
fe
re
nc
e. 
Se
x-
sp
ec
ifi
c c
ut
 p
oi
nt
s f
or
 w
ai
st-
to
-h
ip
 ra
tio
 fr
om
 B
ra
y.
36
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